VereCoV™ (IVD)

VereCoV™ Detection Kit is a multiplex RT-PCR and microarray-based test. This test is for use in conjunction with the VerePLEX™ Biosystem. The test is intended for qualitative detection, differentiation and identification of the following viral RNA in a single test.

  • 2019 Novel Coronavirus (2019-nCoV)
  • Severe Acute Respiratory Syndrome-related Coronavirus (SARS-CoV)

Enhanced screening measures against COVID-19 have been implemented at all Singapore immigration checkpoints. Travellers entering Singapore will undergo temperature screening but those displaying symptoms of respiratory illnesses or fever will be requested to undergo nasal swab test. These specimens will be transported to the Home Team Science and Technology Agency (HTX) laboratory at Pasir Panjang, where scientists will use VereCoV™ Detection Kit to determine if specimens contain the 2019 Novel Coronavirus (2019-nCoV)

Read the full story:

Channel News Asia – New COVID-19 test kits used to screen swab samples collected at Singapore checkpoints

Today – New COVID-19 test kit deployed at all Singapore checkpoints detects its first imported case

Watch the news commentary:

 

VereCoV™ Detection Kit is a multiplex RT-PCR and microarray-based test. This test is for use in conjunction with the VerePLEX™ Biosystem. The test is intended for qualitative detection, differentiation and identification of the following viral RNA in a single test.

  • 2019 Novel Coronavirus (2019-nCoV)
  • Severe Acute Respiratory Syndrome-related Coronavirus (SARS-CoV)

VereCoV™ Detection Kit and VerePLEX™ Biosystem are issued with Provisional Authorisation from the Heath Sciences Authority (Singapore) as medical devices to supply in Singapore intended for In-vitro Diagnostic (IVD) use.

Please contact your local Veredus Laboratories sales representative or distributor for more information.

View Workflow Video